EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Recent Evidence on Cardiac 99m Tc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis

Federico Caobelli

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.123.266676 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Federico Caobelli. Hauptthemen laut MEDLINE: Amyloidosis, Cardiomyopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TO THE EDITOR: In recent years, the management of patients with amyloid transthyretin–related (ATTR) cardiac amyloidosis (CA) has undergone major changes because of the validation of effective therapies. For example, new treatment with antibodies such as N1006 showed promise in depleting ATTR CA

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidosisCardiomyopathiesHumansHeartBenzoxazolesPrealbumin

Substanzen

tafamidisBenzoxazolesPrealbumin

Zitieren

APA

Caobelli, F. (2024). Recent Evidence on Cardiac 99m Tc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.266676

Vancouver

Caobelli F. Recent Evidence on Cardiac 99m Tc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.266676

BibTeX
@article{Caobelli2024,
  author = {Caobelli, Federico},
  title = {Recent Evidence on Cardiac 99m Tc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.123.266676}
}
Kostenlos starten →